{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:00:22Z","timestamp":1761170422495,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.hjc.2021.01.012","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T04:47:24Z","timestamp":1612327644000},"page":"135-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A critical appraisal of the pharmacological management of stable angina"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8364-3447","authenticated-orcid":false,"given":"Dimitrios","family":"Farmakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9439-3946","authenticated-orcid":false,"given":"Andrew","family":"Xanthopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6433-4016","authenticated-orcid":false,"given":"Filippos","family":"Triposkiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hjc.2021.01.012_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2021.01.012_bib2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jacc.2012.02.082","article-title":"Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!","volume":"60","author":"Marzilli","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2021.01.012_bib3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","article-title":"Coronary microvascular dysfunction: an update","volume":"35","author":"Crea","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2021.01.012_bib4","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.yjmcc.2008.03.019","article-title":"Late sodium current inhibition as a new cardioprotective approach","volume":"44","author":"Hale","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hjc.2021.01.012_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.hjc.2020.12.006","article-title":"Collaborators from hospital clinics; Collaborators from private practice offices. Clinical characteristics and management of patients with diabetes mellitus and stable coronary artery disease in daily clinical practice. The SCAD-DM Registry","author":"Marketou","year":"2021","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2021.01.012_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.hjc.2018.06.003","article-title":"The importance of characteristics of angina symptoms for the prediction of coronary artery disease in a cohort of stable patients in the modern era","volume":"60","author":"Nakas","year":"2019","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2021.01.012_bib7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2021.01.012_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"ORBITA investigators. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.hjc.2021.01.012_bib9","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial Invasive or Conservative Strategy for Stable Coronary Disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2021.01.012_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.hjc.2020.08.006","article-title":"ISCHEMIA trial: Is there enough evidence to drive a change in clinical practice? A critical appraisal","volume":"61","author":"Tziakas","year":"2020","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2021.01.012_bib11","article-title":"Application and clinical implications of revascularization on chronic coronary syndromes: From COURAGE to ISCHEMIA trial","author":"Tsigkas","year":"2020","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2021.01.012_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa072771","article-title":"Effect of PCI on quality of life in patients with stable coronary disease","volume":"359","author":"Weintraub","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2021.01.012_bib13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/FJC.0000000000000716","article-title":"Practical Recommendations for the Diagnosis and Medical Management of Stable Angina: An Expert Panel Consensus","volume":"74","author":"Farmakis","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.hjc.2021.01.012_bib14","article-title":"Association of systemic inflammatory biomarkers with morphological characteristics of coronary atherosclerotic plaque by intravascular optical coherence tomography","author":"Koganti","year":"2020","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2021.01.012_bib15","article-title":"Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis","author":"Aimo","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.hjc.2021.01.012_bib16","article-title":"Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","author":"Samuel","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hjc.2021.01.012_bib17","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2021.01.012_bib18","article-title":"Ranolazine: A Contemporary Review","volume":"5","author":"Hartley","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hjc.2021.01.012_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2020.05.020","article-title":"Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry)","volume":"129","author":"Storey","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hjc.2021.01.012_bib20","first-page":"100554","article-title":"The New ESC Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes: the Good and the Not So Good","author":"Ferrari","year":"2020","journal-title":"Curr Probl Cardiol"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966621000129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966621000129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:13:35Z","timestamp":1761099215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966621000129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1109966621000129"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2021.01.012","relation":{},"ISSN":["1109-9666"],"issn-type":[{"type":"print","value":"1109-9666"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A critical appraisal of the pharmacological management of stable angina","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2021.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}